Sort By:
| Votes | Story |
|---|---|
|
1
|
FivePrime achieves target discovery milestone with Boehringer Ingelheim
Five Prime Therapeutics, Inc., the protein therapeutics discovery and development company, today announced that it has successfully achieved a target...
|
|
1
|
Five Prime enters Osteoarthritis and Pulmonary Fibrosis Collaboration with Centocor
Five Prime Therapeutics, Inc. today announced a worldwide collaborative research and license agreement with Centocor Research and Development Inc. The...
|
|
1
|
Mark McDade to join FivePrime Board of Directors
Five Prime Therapeutics, Inc. today announced that it has appointed Mark McDade, CEO of PDL BioPharma, Inc, to the FivePrime Board of Directors.
|
« Previous
1
2
3
4
5
6
7
8
9
10
Next »
Web Metrics
View All Web Metrics »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.


Profile
Opinions
